OCT-guided reinjection of 2.5 mg bevacizumab for treating macular edema due to retinal vein occlusion;OCT-Befund als Reinjektionskriterium für die 2,5-mg-Bevacizumab- Therapie bei venösen retinalen Verschlüssen

Ophthalmologe

Volumn 105, Issue 12, 2008, Pages 1121-1126

  Hoh A E ^a   Schaal, K B ^a   Scheuerle, A ^a   Schutt F ^a   Dithmar, S ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Bevacizumab; Branch retinal vein occlusion; Central retinal vein occlusion; Macular edema; OCT

Indexed keywords

EID: 57849135013     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-008-1759-2     Document Type: Article

References (16)

1. Bakri 2007 Ophthalmology 114 855
2. Beer 2006 Retina 26 871
3. Costa 2007 Retina 27 141
4. Gaudreault 2005 Invest Ophthalmol Vis Sci 46 726
5. Iturralde 2006 Retina 26 279
6. Jaissle 2006 Ophthalmologe 103 471
7. Kernt 2007 Ophthalmologe 104 965
8. Luthra 2006 Retina 26 512
9. Manzano 2006 Retina 26 257
10. Matsumoto 2007 Retina 27 426
11. Mordenti 1999 Toxicol Pathol 27 536
12. Pai 2007 Am J Ophthalmol 143 601
13. Rabena 2007 Retina 27 419
14. Schaal 2007 Ophthalmologe 104 285
15. Spandau 2006 Acta Ophthalmol Scand 84 555
16. Stahl 2007 Graefes Arch Clin Exp Ophthalmol 245 1429